Evaluation of RC28-E Injection in Wet Age-related Macular Degeneration
Clinical trial NCT04270669 · COMPLETED
Trial details
- NCT number
- NCT04270669
- Sponsor
- RemeGen Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-15
- Primary completion
- 2021-10-29
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.